5.4 Use in Women of Childbearing Potential Because of the risk to the fetus of decreased IQ, neurodevelopmental disorders, and major congenital malformations (including neural tube defects), which may occur very early in pregnancy, valproate should not be administered to a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable
Those claims are being handled in federal court alongside other related GLP-1 drug cases, and additional state-court vision-loss cases have also been filed
Supplementation with the glutathione precursor cysteine restores antioxidant status
Ipamorelin activates GHS-R1a through Gq-coupled phospholipase C, increasing IP3 and intracellular calcium, which triggers vesicle fusion and exocytosis
India's GLP-1 receptor agonist market is expanding rapidly, driven by the rising incidence of obesity and diabetes
M.DelaneyA.JonesD.RoncoC.BellomoR